XML 35 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (USD $)
9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Cash flows from operating activities:    
Net loss $ (1,728,357) $ (1,652,618)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 3,031 2,131
Amortization of debt issuance costs 54,370 67,245
Accretion of discount on convertible debentures 560,081 319,225
Interest income on short-term investment (24) (115)
Change in fair value of conversion option and warrant liabilities (508,974) (290,973)
Stock-based compensation 203,695 305,517
Loss on extinguishment of debt 1,104,179   
Bad debts expense 36,099   
Return of unvested consultant stock (45,000)   
Changes in operating assets and liabilities:    
Accounts receivable (98,019) (390,299)
Costs and estimated earnings in excess of billings on uncompleted contracts    (287,894)
Inventory 455 (164,914)
Prepaid expenses and other current assets (8,224) (8,088)
Security deposit    (12,000)
Accounts payable and accrued expenses (64,410) 602,323
Accrued interest, related party 6,131 6,131
Accrued interest (9,458) 51,530
Related party accounts payable and accrued expenses (80,961) 105,514
Billings in excess of costs and estimated earnings -on uncompleted contracts (19,467) (42,790)
Deferred revenue (54,051) 237,742
Net cash used in operating activities (648,904) (1,152,333)
Cash flows used in investing activities    
Purchase of equipment (3,069) (8,785)
Net cash used in investing activities (3,069) (8,785)
Cash flows from financing activities:    
Expenditures on debt issuance costs (40,763) (28,000)
Proceeds from exercise of stock options 10,000   
Proceeds from issuance of convertible debentures and warrants 1,760,858 850,000
Principal payment of convertible debentures (392,000)   
Net cash provided by financing activities 1,338,095 822,000
Effect of exchange rate changes on cash    (4,369)
Net increase (decrease) in cash 686,122 (343,487)
Cash and cash equivalents - beginning of period 594,248 868,067
Cash and cash equivalents - end of period 1,280,370 524,580
Cash paid during the period for:    
Interest 209,966   
Supplemental disclosure of non-cash financing activities:    
In connection with the issuance of convertible debentures, $40,000 was paid for accrued interest and $24,142 was paid for debt issuance costs.